| __timestamp | Bausch Health Companies Inc. | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 4326000 |
| Thursday, January 1, 2015 | 2682700000 | 226206000 |
| Friday, January 1, 2016 | 2810000000 | 94391000 |
| Sunday, January 1, 2017 | 2582000000 | 53821000 |
| Monday, January 1, 2018 | 2473000000 | 35463000 |
| Tuesday, January 1, 2019 | 2554000000 | 46456000 |
| Wednesday, January 1, 2020 | 2367000000 | 71318000 |
| Friday, January 1, 2021 | 2624000000 | 135256000 |
| Saturday, January 1, 2022 | 2625000000 | 102708000 |
| Sunday, January 1, 2023 | 2917000000 | 129620000 |
Cracking the code
In the competitive landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. Bausch Health Companies Inc. and ImmunityBio, Inc. offer a fascinating study in contrasts when it comes to Selling, General, and Administrative (SG&A) expenses from 2014 to 2023. Bausch Health, a giant in the sector, consistently reported SG&A expenses that were over 20 times higher than those of ImmunityBio, reflecting its expansive operations and market reach. Notably, Bausch Health's expenses peaked in 2023, showing a 44% increase from 2014. In contrast, ImmunityBio, a smaller player, demonstrated a more volatile pattern, with a significant spike in 2015, where expenses surged by over 5000% compared to the previous year. This divergence highlights the varied financial strategies and operational scales of these companies, offering insights into their market positioning and growth trajectories.
Operational Costs Compared: SG&A Analysis of Amgen Inc. and Bausch Health Companies Inc.
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or ImmunityBio, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing BeiGene, Ltd. and Bausch Health Companies Inc.
Insmed Incorporated or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Ascendis Pharma A/S or Bausch Health Companies Inc.: Who Manages SG&A Costs Better?
Grifols, S.A. vs Bausch Health Companies Inc.: SG&A Expense Trends
Breaking Down SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Who Optimizes SG&A Costs Better? Bausch Health Companies Inc. or Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and Supernus Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: ImmunityBio, Inc. vs Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and MiMedx Group, Inc.